|
Characteristics
|
EV71 vaccination coverage(≥1dose)
|
EV71 vaccination coverage on-timea
|
|---|
|
No.
|
rate %(95%CI)
|
No.
|
rate %(95%CI)
|
|---|
|
Total
|
172,236
|
24.05(23.95–24.15)
|
61,661
|
8.61(8.54–8.67)
|
|
Sex
|
|
Male
|
90,124
|
23.77(23.64–23.91)
|
32,081
|
8.46(8.37–8.55)
|
|
Female
|
82,112
|
24.36(24.22–24.51)
|
29,580
|
8.78(8.68–8.87)
|
|
Immigration status
|
|
Resident children
|
87,935
|
26.24(26.09–26.39)
|
33,512
|
10.00(9.90–10.10)
|
|
Migrant children
|
84,162
|
22.13(22.00–22.26)
|
28,095
|
7.39(7.30–7.47)
|
|
Foreign children
|
139
|
19.31(16.48–22.38)
|
54
|
7.50(5.68–9.67)
|
|
Urbanicity
|
|
Inner
|
110,989
|
27.97(27.83–28.11)
|
44,136
|
11.12(11.03–11.22)
|
|
Outer
|
61,247
|
19.18(19.04–19.31)
|
17,525
|
5.49(5.41–5.57)
|
|
Birth year
|
|
2012
|
501
|
0.49(0.45–0.53)
|
N/A
|
N/A
|
|
2013
|
2675
|
2.79(2.68–2.89)
|
N/A
|
N/A
|
|
2014
|
10,822
|
10.05(9.87–10.23)
|
N/A
|
N/A
|
|
2015
|
22,590
|
23.19(22.92–23.45)
|
338
|
0.35(0.31–0.39)
|
|
2016
|
42,677
|
38.28(37.99–38.56)
|
10,316
|
9.25(9.08–9.42)
|
|
2017
|
50,826
|
48.00(47.70–48.30)
|
21,998
|
20.77(20.53–21.02)
|
|
2018
|
42,145
|
44.23(43.92–44.55)
|
29,009
|
30.45(30.15–30.74)
|
|
Socioeconomic level of resident areas
|
|
High
|
76,556
|
29.62(29.44–29.79)
|
33,244
|
12.86(12.73–12.99)
|
|
Low
|
95,680
|
20.90(20.79–21.02)
|
28,417
|
6.21(6.14–6.28)
|
|
Scale of immunization clinics
|
|
Large-scaled
|
76,687
|
24.45(24.30–24.60)
|
31,915
|
10.18(10.07–10.28)
|
|
Midsized
|
43,279
|
23.94(23.74–24.14)
|
12,280
|
6.79(6.68–6.91)
|
|
Small-sized
|
52,270
|
23.57(23.39–23.75)
|
17,466
|
7.88(7.76–7.98)
|
- aEV71 vaccination on-time was defined as receiving at least 1 dose of EV71 vaccine during 6-12 months of age
